Difference between revisions of "Template:Hallucinogens"
Jump to navigation
Jump to search
imported>David Hedlund |
imported>Meodipt |
||
| (218 intermediate revisions by 35 users not shown) | |||
| Line 2: | Line 2: | ||
|name= Hallucinogens | |name= Hallucinogens | ||
|title= [[Hallucinogen]]s | |title= [[Hallucinogen]]s | ||
| − | |state= {{{state| | + | |state= {{{state<includeonly>|collapsed</includeonly>}}} |
|listclass= hlist | |listclass= hlist | ||
| + | |group1= [[Psychedelic drug|Psychedelics]]<br /><small>([[5-HT2A receptor|5-HT<sub>2A</sub>]]<br />agonists)</small> | ||
| + | |list1= | ||
| + | {{Navbox|subgroup | ||
| + | |group1=[[Substituted benzofuran|Benzofuran]]s | ||
| + | |list1= | ||
| + | * [[2C-B-FLY]] | ||
| + | * [[2CBFly-NBOMe]] | ||
| + | * [[5-MeO-BFE]] | ||
| + | * [[5-MeO-DiBF]] | ||
| + | * [[Bromo-DragonFLY]] | ||
| + | * [[F-2_(drug)|F-2]] | ||
| + | * [[F-22_(psychedelic)|F-22]] | ||
| + | * [[TFMFly]] | ||
| − | + | |group2= [[Lysergamides|Lyserg‐<br />amides]] | |
| − | + | |list2= | |
| − | + | * [[1B-LSD]]<!-- {{DOI|10.1007/s00216-018-1558-9}}. --> | |
| − | + | * [[1cP-LSD]]<!-- doi:10.1002/dta.2789 --> | |
| − | + | * [[1P-ETH-LAD]] | |
| + | * [[1P-LSD]] | ||
| + | * [[Lysergic acid 2-butyl amide|2-Butyllysergamide]] | ||
| + | * [[Lysergic acid 3-pentyl amide|3-Pentyllysergamide]] | ||
* [[AL-LAD]] | * [[AL-LAD]] | ||
* [[ALD-52]] | * [[ALD-52]] | ||
* [[BU-LAD]] | * [[BU-LAD]] | ||
| − | |||
| − | |||
* [[Diallyllysergamide]] | * [[Diallyllysergamide]] | ||
* [[Dimethyllysergamide]] | * [[Dimethyllysergamide]] | ||
| + | * [[ECPLA]]<!-- Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) doi: 10.1007/s00213-018-5055-9 --> | ||
* [[Ergometrine]] | * [[Ergometrine]] | ||
* [[ETH-LAD]] | * [[ETH-LAD]] | ||
| + | * [[IP-LAD]] | ||
* [[LAE-32]] | * [[LAE-32]] | ||
| + | * [[LAMPA]]<!-- Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA) doi: 10.1007/s00213-018-5055-9 --> | ||
* [[LPD-824]] | * [[LPD-824]] | ||
* [[Ergine|LSA]] | * [[Ergine|LSA]] | ||
| Line 26: | Line 43: | ||
* [[Lysergic acid hydroxyethylamide|LSH]] | * [[Lysergic acid hydroxyethylamide|LSH]] | ||
* [[LSM-775]] | * [[LSM-775]] | ||
| − | |||
* [[Lysergic acid 2,4-dimethylazetidide|LSZ]] | * [[Lysergic acid 2,4-dimethylazetidide|LSZ]] | ||
| − | |||
* [[Methylergometrine]] | * [[Methylergometrine]] | ||
| − | * [[Methylisopropyllysergamide]] | + | * [[Methylisopropyllysergamide|MIPLA]] |
* [[Methysergide]] | * [[Methysergide]] | ||
| − | * [[N1-Methyl-lysergic acid diethylamide]] | + | * [[N1-Methyl-lysergic acid diethylamide|MLD-41]] |
* [[PARGY-LAD]] | * [[PARGY-LAD]] | ||
* [[PRO-LAD]] | * [[PRO-LAD]] | ||
| − | | | + | |
| − | | | + | |group3= [[Substituted phenethylamine|Phenethyl‐<br />amines]] |
| − | + | |list3= | |
| − | * [[ | + | {{Navbox|subgroup |
| − | * [[ | + | |group1=[[2C (psychedelics)|2C-''x'']] |
| − | * [[ | + | |list1={{2C_(psychedelics)-list}} |
| − | * [[ | + | |
| − | * [[ | + | {{Navbox|subgroup |
| − | * [[ | + | |group1=[[25-NB|25''x''-NB''x'']] |
| − | * [[ | + | |list1= |
| − | * [[ | + | |
| − | * [[ | + | {{Navbox|subgroup |
| + | |||
| + | |group1=25''x''-<abbr title="NB: N-benzyl">NB</abbr> | ||
| + | |list1= | ||
| + | * [[25B-NB]] | ||
| + | * [[25C-NB]] | ||
| + | |||
| + | |group2=25''x''-<abbr title="NB: N-benzyl; 3OMe: 3-methoxy">NB3OMe</abbr> | ||
| + | |list2= | ||
| + | * [[25B-NB3OMe]] | ||
| + | * [[25C-NB3OMe]] | ||
| + | * [[25D-NB3OMe]] | ||
| + | * [[25E-NB3OMe]] | ||
| + | * [[25H-NB3OMe]] | ||
| + | * [[25I-NB3OMe]] | ||
| + | * [[25N-NB3OMe]] | ||
| + | * [[25P-NB3OMe]] | ||
| + | * [[25T2-NB3OMe]] | ||
| + | * [[25T4-NB3OMe]] | ||
| + | * [[25T7-NB3OMe]] | ||
| + | * [[25TFM-NB3OMe]] | ||
| + | |||
| + | |group3=25''x''-<abbr title="NB: N-benzyl; 4OMe: 4-methoxy">NB4OMe</abbr> | ||
| + | |list3= | ||
| + | * [[25B-NB4OMe]] | ||
| + | * [[25C-NB4OMe]] | ||
| + | * [[25D-NB4OMe]] | ||
| + | * [[25E-NB4OMe]] | ||
| + | * [[25H-NB4OMe]] | ||
| + | * [[25I-NB4OMe]] | ||
| + | * [[25N-NB4OMe]] | ||
| + | * [[25P-NB4OMe]] | ||
| + | * [[25T2-NB4OMe]] | ||
| + | * [[25T4-NB4OMe]] | ||
| + | * [[25T7-NB4OMe]] | ||
| + | * [[25TFM-NB4OMe]] | ||
| + | |||
| + | |||
| + | |group4=25''x''-<abbr title="NB: N-benzyl; F: fluoro">NBF</abbr> | ||
| + | |list4= | ||
| + | * [[25B-NBF]] | ||
| + | * [[25C-NBF]] | ||
| + | * [[25D-NBF]] | ||
| + | * [[25E-NBF]] | ||
| + | * [[25H-NBF]] | ||
| + | * [[25I-NBF]] | ||
| + | * [[25P-NBF]] | ||
| + | * [[25T2-NBF]] | ||
| + | * [[25T7-NBF]] | ||
| + | * [[25TFM-NBF]] | ||
| + | |||
| + | |group5=25''x''-<abbr title="NB: N-benzyl; MD: methylenedioxy">NBMD</abbr> | ||
| + | |list5= | ||
| + | * [[25B-NBMD]] | ||
| + | * [[25C-NBMD]] | ||
| + | * [[25D-NBMD]] | ||
| + | * [[25E-NBMD]] | ||
| + | * [[25F-NBMD]] | ||
| + | * [[25H-NBMD]] | ||
| + | * [[25I-NBMD]] | ||
| + | * [[25P-NBMD]] | ||
| + | * [[25T2-NBMD]] | ||
| + | * [[25T7-NBMD]] | ||
| + | * [[25TFM-NBMD]] | ||
| + | |||
| + | |group6=25''x''-<abbr title="NB: N-benzyl; OH: hydroxy">NBOH</abbr> | ||
| + | |list6= | ||
| + | * [[25B-NBOH]] | ||
| + | * [[25C-NBOH]] | ||
| + | * [[25CN-NBOH]] | ||
| + | * [[25D-NBOH]] | ||
| + | * [[25E-NBOH]] | ||
| + | * [[25F-NBOH]] | ||
| + | * [[25H-NBOH]] | ||
| + | * [[25I-NBOH]] | ||
| + | * [[25P-NBOH]] | ||
| + | * [[25T2-NBOH]] | ||
| + | * [[25T7-NBOH]] | ||
| + | * [[25TFM-NBOH]] | ||
| + | |||
| + | |group7=25''x''-<abbr title="NB: N-benzyl; OMe: methoxy">NBOMe</abbr> | ||
| + | |list7= | ||
| + | * [[25B-NBOMe]] | ||
* [[25C-NBOMe]] | * [[25C-NBOMe]] | ||
| − | |||
* [[25CN-NBOMe]] | * [[25CN-NBOMe]] | ||
* [[25D-NBOMe]] | * [[25D-NBOMe]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
* [[25E-NBOMe]] | * [[25E-NBOMe]] | ||
| − | |||
| − | |||
* [[25F-NBOMe]] | * [[25F-NBOMe]] | ||
| − | |||
* [[25G-NBOMe]] | * [[25G-NBOMe]] | ||
* [[25H-NBOMe]] | * [[25H-NBOMe]] | ||
| − | * [[ | + | * [[25I-NBOMe]] |
| − | * [[ | + | * [[25iP-NBOMe]] |
| − | |||
| − | |||
* [[25N-NBOMe]] | * [[25N-NBOMe]] | ||
| − | * [[ | + | * [[25P-NBOMe]] |
| − | * [[ | + | * [[25T-NBOMe]] |
| − | + | * [[25T2-NBOMe]] | |
| − | |||
| − | |||
| − | * [[ | ||
* [[25T4-NBOMe]] | * [[25T4-NBOMe]] | ||
| − | + | * [[25T7-NBOMe]] | |
| − | |||
| − | * [[25T7- | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[25TFM-NBOMe]] | * [[25TFM-NBOMe]] | ||
| − | * [[ | + | |
| − | * [[ | + | |group8=Atypical structures |
| + | |list8= | ||
| + | * [[25B-N1POMe]] | ||
| + | * [[25B-NAcPip]] | ||
| + | * [[25B-NB23DM]] | ||
| + | * [[25B-NB25DM]] | ||
| + | * [[25C-NBCl]] | ||
| + | * [[25C-NBOEt]] | ||
| + | * [[25C-NBOiPr]] | ||
| + | * [[25I-N2Nap1OH]] | ||
| + | * [[25I-N3MT2M]] | ||
| + | * [[25I-N4MT3M]] | ||
| + | * [[25I-NB34MD]] | ||
| + | * [[25I-NBAm]] | ||
| + | * [[25I-NBBr]] | ||
| + | * [[25I-NBMeOH]] | ||
| + | * [[25I-NBTFM]] | ||
* [[2CBCB-NBOMe]] | * [[2CBCB-NBOMe]] | ||
* [[2CBFly-NBOMe]] | * [[2CBFly-NBOMe]] | ||
| − | * [[ | + | * [[4-EA-NBOMe]] |
| − | * [[25B- | + | * [[5-APB-NBOMe]] |
| − | * [[25B- | + | * [[5MT-NBOMe]] |
| − | * [[ | + | * [[C30-NBOMe]] |
| − | * [[ | + | * [[DOB-NBOMe]] |
| − | * [[25I- | + | * [[DOI-NBOMe]] |
| − | * [[25I- | + | * [[FECIMBI-36]] |
| − | * [[25I- | + | * [[MDPEA-NBOMe]] |
| − | * [[ | + | * [[NBOMe-escaline]] |
| + | * [[NBOMe-mescaline]] | ||
| + | * [[ZDCM-04]] | ||
| + | |||
| + | }} | ||
| + | |||
| + | |group2=25''x''-NM''x'' | ||
| + | |list2= | ||
| + | * [[25B-NMe7BF]] | ||
| + | * [[25B-NMe7BT]] | ||
| + | * [[25B-NMe7Box]] | ||
| + | * [[25B-NMe7DHBF]] | ||
| + | * [[25B-NMe7Ind]] | ||
| + | * [[25B-NMe7Indz]] | ||
| + | * [[25B-NMePyr]] | ||
| + | * [[25I-NMe7DHBF]] | ||
| + | * [[25I-NMeFur]] | ||
| + | * [[25I-NMeTHF]] | ||
| + | * [[25I-NMeTh]] | ||
| + | |||
| + | }} | ||
| + | |||
| + | |group3=3C-''x'' | ||
| + | |list3= | ||
* [[3C-AL]] | * [[3C-AL]] | ||
| + | * [[3C-BZ]] | ||
| + | * [[3C-DFE]] | ||
* [[3C-E]] | * [[3C-E]] | ||
| + | * [[3C-MAL]] | ||
* [[3C-P]] | * [[3C-P]] | ||
| − | * [[ | + | |
| − | * [[ | + | |group4=4C-''x'' |
| − | * [[ | + | |list4= |
| − | * [[ | + | * [[4C-B]] |
| − | * [[ | + | * [[4C-C]] |
| − | * [[ | + | * [[4C-D]] |
| − | * [[ | + | * [[4C-E]] |
| − | * [[ | + | * [[4C-I]] |
| − | + | * [[4C-N]] | |
| − | + | * [[4C-P]] | |
| − | * [[ | + | * [[4C-T-2]] |
| + | |||
| + | |group5=[[DOx|DO''x'']] | ||
| + | |list5= | ||
| + | * [[Aleph (psychedelic)|DOT]] | ||
* [[2,5-Dimethoxy-4-bromoamphetamine|DOB]] | * [[2,5-Dimethoxy-4-bromoamphetamine|DOB]] | ||
| − | |||
* [[2,5-Dimethoxy-4-chloroamphetamine|DOC]] | * [[2,5-Dimethoxy-4-chloroamphetamine|DOC]] | ||
* [[2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine|DOEF]] | * [[2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine|DOEF]] | ||
| Line 119: | Line 239: | ||
* [[2,5-Dimethoxy-4-fluoroamphetamine|DOF]] | * [[2,5-Dimethoxy-4-fluoroamphetamine|DOF]] | ||
* [[2,5-Dimethoxy-4-iodoamphetamine|DOI]] | * [[2,5-Dimethoxy-4-iodoamphetamine|DOI]] | ||
| + | * [[2,5-Dimethoxy-4-isopropylamphetamine|DOiPR]] | ||
* [[2,5-Dimethoxy-4-methylamphetamine|DOM]] | * [[2,5-Dimethoxy-4-methylamphetamine|DOM]] | ||
| − | |||
* [[2,5-Dimethoxy-4-nitroamphetamine|DON]] | * [[2,5-Dimethoxy-4-nitroamphetamine|DON]] | ||
* [[2,5-Dimethoxy-4-propylamphetamine|DOPR]] | * [[2,5-Dimethoxy-4-propylamphetamine|DOPR]] | ||
* [[2,5-Dimethoxy-4-trifluoromethylamphetamine|DOTFM]] | * [[2,5-Dimethoxy-4-trifluoromethylamphetamine|DOTFM]] | ||
| − | * [[ | + | * [[2,5-Dimethoxy-4-ethoxyamphetamine|MEM]] |
| − | + | ||
| − | + | |group6=HOT-''x'' | |
| − | + | |list6= | |
* [[HOT-2]] | * [[HOT-2]] | ||
* [[HOT-7]] | * [[HOT-7]] | ||
* [[HOT-17]] | * [[HOT-17]] | ||
| − | * [[ | + | |
| − | * [[ | + | |group7=[[Substituted methylenedioxyphenethylamine|MD<em>xx</em>]] |
| + | |list7= | ||
| + | * [[DMMDA]] | ||
| + | * [[2,3-Dimethoxy-4,5-methylenedioxyamphetamine|DMMDA-2]] | ||
* [[Lophophine]] | * [[Lophophine]] | ||
| − | |||
* [[3,4-Methylenedioxyamphetamine|MDA]] | * [[3,4-Methylenedioxyamphetamine|MDA]] | ||
| − | * [[ | + | * [[MDBZ]] |
| − | |||
| − | |||
| − | |||
| − | |||
* [[MMDA (drug)|MMDA]] | * [[MMDA (drug)|MMDA]] | ||
* [[MMDA-2]] | * [[MMDA-2]] | ||
* [[MMDA-3a]] | * [[MMDA-3a]] | ||
| − | * [[MMDMA ( | + | * [[MMDMA]] |
| − | * [[ | + | |
| + | |group8=Mescaline (subst.) | ||
| + | |list8= | ||
| + | * [[2-Bromomescaline]] | ||
| + | * [[Thioescaline|3-TE]] | ||
| + | * [[Thioescaline|4-TE]] | ||
| + | * [[Thiomescaline|3-TM]] | ||
| + | * [[Thiomescaline|4-TM]] | ||
| + | * [[Allylescaline]] | ||
| + | * [[Asymbescaline]] | ||
| + | * [[Buscaline]] | ||
| + | * [[Cyclopropylmescaline]] | ||
| + | * [[Difluoromescaline]] | ||
| + | * [[Difluoroescaline]] | ||
| + | * [[Escaline]] | ||
| + | * [[Fluoroproscaline]] | ||
| + | * [[Isobuscaline]] | ||
| + | * [[Isoproscaline]] | ||
| + | * [[Jimscaline]] | ||
| + | * [[Mescaline]] | ||
| + | * [[Metaescaline]] | ||
| + | * [[Methallylescaline]] | ||
* [[Proscaline]] | * [[Proscaline]] | ||
| + | * [[Thioproscaline]] | ||
| + | * [[Trifluoroescaline]] | ||
| + | * [[Trifluoromescaline]] | ||
| + | |||
| + | |group9=[[Trimethoxyamphetamine|TMAs]] | ||
| + | |list9= | ||
| + | * TMA | ||
| + | * TMA-2 | ||
| + | * TMA-3 | ||
| + | * TMA-4 | ||
| + | * TMA-5 | ||
| + | * TMA-6 | ||
| + | |||
| + | |group10=Others | ||
| + | |list10= | ||
| + | * [[2C-B-BUTTERFLY]] | ||
| + | * [[2C-B-DragonFLY]] | ||
| + | * [[2C-B-DragonFLY-NBOH]] | ||
| + | * [[2C-B-FLY-NB2EtO5Cl]] | ||
| + | * [[2CB-5-hemifly]] | ||
| + | * [[2CB-Ind]] | ||
| + | * [[2CD-5EtO]] | ||
| + | * [[TOET_(psychedelic)#2-TOET|2-TOET]] | ||
| + | * [[TOET_(psychedelic)#5-TOET|5-TOET]] | ||
| + | * [[TOM (psychedelic)|2-TOM]] | ||
| + | * [[TOM (psychedelic)|5-TOM]] | ||
| + | * [[BOB (psychedelic)|BOB]] | ||
| + | * [[BOD (psychedelic)|BOD]] | ||
| + | * [[βk-2C-B]] | ||
| + | * [[βk-2C-I]] | ||
| + | * [[DESOXY]] | ||
| + | * [[2,5-Dimethoxy-4-methylphenylcyclopropylamine|DMCPA]] | ||
| + | * [[DMBMPP]] | ||
| + | * [[DOB-FLY]] | ||
| + | * [[Fenfluramine]] | ||
| + | * [[Ganesha (psychedelic)|Ganesha]] | ||
| + | * [[Macromerine]] | ||
| + | * [[3-Methoxy-4-methylamphetamine|MMA]] | ||
* [[TCB-2]] | * [[TCB-2]] | ||
| − | * [[ | + | * [[TOMSO]] |
| − | + | }} | |
| − | | | + | |
| − | + | |group4= [[Substituted piperazine|Piperazine]]s | |
| + | |list4= | ||
| + | * [[2C-B-PP]] | ||
| + | * [[Benzylpiperazine|BZP]] | ||
* [[para-Fluorophenylpiperazine|pFPP]] | * [[para-Fluorophenylpiperazine|pFPP]] | ||
| − | * [[ | + | |
| − | * [[ | + | |group5= [[Substituted tryptamine|Tryptamine]]s |
| − | + | |list5= | |
| − | + | {{Navbox|subgroup | |
| − | * [[1- | + | |group1=[[Substituted alpha-alkyltryptamine|''alpha''-alkyltryptamine]]s |
| + | |list1= | ||
| + | * [[AL-37350A|4,5-DHP-α-MT]] | ||
| + | * [[5-MeO-AET|5-MeO-α-ET]] | ||
| + | * [[5-MeO-aMT|5-MeO-α-MT]] | ||
| + | * [[alpha-Ethyltryptamine|α-ET]] | ||
| + | * [[alpha-Methyltryptamine|α-MT]] | ||
| + | |||
| + | |group2=''x''-<abbr title="N,N-Diallyltryptamine">DALT</abbr> | ||
| + | |list2= | ||
| + | * [[4-HO-DALT|(Daltocin) 4-HO-DALT]] | ||
| + | * [[4-AcO-DALT|(Daltacetin) 4-AcO-DALT]] | ||
| + | * [[5-MeO-DALT]] | ||
| + | * [[DALT]] | ||
| + | |||
| + | |group3=''x''-<abbr title="N,N-Diethyltryptamine">DET</abbr> | ||
| + | |list3= | ||
| + | * [[4-Acetoxy-DET|(Ethacetin) 4-AcO-DET]] | ||
| + | * [[4-HO-DET|(Ethocin) 4-HO-DET]] | ||
| + | * [[5-MeO-DET]] | ||
| + | * [[Diethyltryptamine|(T-9) DET]] | ||
| + | * [[Ethocybin|(Ethocybin) 4-PO-DET]] | ||
| + | |||
| + | |group4=''x''-<abbr title="N,N-Diisopropyltryptamine">DiPT</abbr> | ||
| + | |list4= | ||
| + | * [[4-Acetoxy-DiPT|(Ipracetin) 4-AcO-DiPT]] | ||
| + | * [[4-HO-DiPT|(Iprocin) 4-HO-DiPT]] | ||
| + | * [[5-Methoxy-N,N-diisopropyltryptamine|5-MeO-DiPT]] | ||
| + | * [[Diisopropyltryptamine|DiPT]] | ||
| + | |||
| + | |group5=''x''-<abbr title=N,N-Dimethyltryptamine>DMT</abbr> | ||
| + | |list5= | ||
| + | * [[1-(2-Dimethylaminoethyl)dihydropyrano(3,2-e)indole|4,5-DHP-DMT]] | ||
* [[2,N,N-TMT]] | * [[2,N,N-TMT]] | ||
| − | + | * [[O-Acetylpsilocin|4-AcO-DMT]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | * [[O-Acetylpsilocin|4- | ||
| − | |||
| − | |||
* [[4-Hydroxy-5-methoxydimethyltryptamine|4-HO-5-MeO-DMT]] | * [[4-Hydroxy-5-methoxydimethyltryptamine|4-HO-5-MeO-DMT]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[4,N,N-TMT]] | * [[4,N,N-TMT]] | ||
* [[4-Propionyloxy-DMT]] | * [[4-Propionyloxy-DMT]] | ||
| Line 178: | Line 378: | ||
* [[5-AcO-DMT]] | * [[5-AcO-DMT]] | ||
* [[5-Bromo-DMT]] | * [[5-Bromo-DMT]] | ||
| − | * [[ | + | * [[(Indapex) 5-MeO-2-TMT|5-MeO-2,''N'',''N''-TMT]] |
| − | |||
* [[5-MeO-4,N,N-TMT|5-MeO-4,''N'',''N''-TMT]] | * [[5-MeO-4,N,N-TMT|5-MeO-4,''N'',''N''-TMT]] | ||
* [[5-MeO-α,N,N-TMT]] | * [[5-MeO-α,N,N-TMT]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[5-MeO-DMT]] | * [[5-MeO-DMT]] | ||
| + | * [[5,N,N-TMT|5-''N'',''N''-TMT]] | ||
| + | * [[7,N,N-TMT]] | ||
| + | * [[Alpha-N,N-Trimethyltryptamine|α,N,N-TMT]] | ||
| + | * [[Bufotenin|(Bufotenin) 5-HO-DMT]] | ||
| + | * [[N,N-Dimethyltryptamine|DMT]] | ||
| + | * [[Norbaeocystin]] | ||
| + | * [[Psilocin|(Psilocin) 4-HO-DMT]] | ||
| + | * [[Psilocybin|(Psilocybin) 4-PO-DMT]] | ||
| + | |||
| + | |group6=''x''-<abbr title="N,N-Dipropyltryptamine">DPT</abbr> | ||
| + | |list6= | ||
| + | * [[4-Acetoxy-DPT|(Depracetin) 4-AcO-DPT]] | ||
| + | * [[4-HO-DPT|(Deprocin) 4-HO-DPT]] | ||
* [[5-MeO-DPT]] | * [[5-MeO-DPT]] | ||
| + | * [[Dipropyltryptamine|(The Light) DPT]] | ||
| + | |||
| + | |group7=Ibogaine-related | ||
| + | |list7= | ||
| + | * [[18-Methylaminocoronaridine|18-MAC]] | ||
| + | * [[18-Methoxycoronaridine|18-MC]] | ||
| + | * [[Coronaridine]] | ||
| + | * [[Ibogaine]] | ||
| + | * [[Ibogamine]] | ||
| + | * [[2-Methoxyethyl-18-methoxycoronaridinate|ME-18-MC]] | ||
| + | * [[Noribogaine]] | ||
| + | * [[Tabernanthine]] | ||
| + | * [[Voacangine]] | ||
| + | |||
| + | |group8=''x''-<abbr title="N-Methyl-N-ethyltryptamine">MET</abbr> | ||
| + | |list8= | ||
| + | * [[4-HO-MET|(Metocin) 4-HO-MET]] | ||
| + | * [[4-AcO-MET|(Metocetin) 4-AcO-MET]] | ||
| + | * [[5-MeO-MET]] | ||
| + | * [[N-Methyl-N-ethyltryptamine|MET]] | ||
| + | |||
| + | |group9=''x''-<abbr title="N-Methyl-N-isopropyltryptamine">MiPT</abbr> | ||
| + | |list9= | ||
| + | * [[4-Acetoxy-MiPT|(Mipracetin) 4-AcO-MiPT]] | ||
| + | * [[4-HO-MiPT|(Miprocin) 4-HO-MiPT]] | ||
| + | * [[5,N-Dimethyl-N-isopropyltryptamine|5-Me-MiPT]] | ||
| + | * [[5-MeO-MiPT|(Moxy) 5-MeO-MiPT]] | ||
| + | * [[Methylisopropyltryptamine|MiPT]] | ||
| + | |||
| + | |group10=Others | ||
| + | |list10= | ||
| + | * [[4-HO-DBT]] | ||
| + | * [[4-HO-EPT]] | ||
| + | * [[4-HO-McPT]] | ||
| + | * [[4-HO-MPMI|(Lucigenol) 4-HO-MPMI]] | ||
| + | * [[4-HO-MPT|(Meprocin) 4-HO-MPT]] | ||
* [[5-MeO-EiPT]] | * [[5-MeO-EiPT]] | ||
| − | * [[5-MeO- | + | * [[5-MeO-MALT]] |
| − | |||
* [[5-MeO-MPMI]] | * [[5-MeO-MPMI]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Aeruginascin]] | * [[Aeruginascin]] | ||
* [[Baeocystin]] | * [[Baeocystin]] | ||
| − | |||
| − | |||
* [[Dibutyltryptamine|DBT]] | * [[Dibutyltryptamine|DBT]] | ||
* [[Dicyclopropyltryptamine|DCPT]] | * [[Dicyclopropyltryptamine|DCPT]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Ethylisopropyltryptamine|EiPT]] | * [[Ethylisopropyltryptamine|EiPT]] | ||
| − | * [[ | + | * [[Ethylpropyltryptamine|EPT]] |
| − | * [[ | + | * [[Methylpropyltryptamine|MPT]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Propylisopropyltryptamine|PiPT]] | * [[Propylisopropyltryptamine|PiPT]] | ||
| − | + | }} | |
| − | + | ||
| − | + | |group6= Others | |
| − | | | + | |list6= |
| − | | | ||
* [[AL-38022A]] | * [[AL-38022A]] | ||
| + | * [[ALPHA (psychedelic)|ALPHA]] | ||
| + | * [[Dimemebfe]] | ||
* [[Efavirenz]] | * [[Efavirenz]] | ||
| − | * [[ | + | * [[Glaucine]] |
| − | * [[ | + | * [[Lorcaserin]] |
| − | * [[RH-34]] | + | * [[M-ALPHA]] |
| + | * [[RH-34]]<br /><small>Also [[empathogen-entactogen|empathogens]] in general (e. g.: [[5-APB]], [[5-MAPB]], [[6-APB]] and other [[substituted benzofuran]]s, [[MDAI]], [[MDMA]]).</small> | ||
}} | }} | ||
| − | | group2 = [[Dissociative]]s<br /> | + | | group2 = [[Dissociative]]s<br /><small>([[NMDA receptor|NMDAR]]<br />[[NMDA receptor antagonist|antagonists]])</small> |
| list2 = | | list2 = | ||
| − | {{Navbox | + | |
| − | | | + | {{Navbox|subgroup |
| − | | | + | |group7= [[Arylcyclohexylamine|Arylcyclo‐<br />hexylamines]] |
| − | + | |list7= | |
| − | + | ||
| − | + | {{Navbox|subgroup | |
| − | + | |group1= Ketamine-related | |
| − | + | |list1= {{Ketamine-related arylcyclohexylamines list}} | |
| − | * [[ | + | |group2= PCP-related |
| − | * [[ | + | |list2= {{PCP-related arylcyclohexylamines list}} |
| − | * [[ | + | |group3= Others |
| + | |list3= | ||
| + | * [[BTCP]] | ||
| + | * [[Gacyclidine]] | ||
| + | * [[PRE-084]] | ||
| + | }} | ||
| + | |||
| + | |group8= Diarylethylamines | ||
| + | |list8= | ||
* [[Diphenidine]] | * [[Diphenidine]] | ||
| − | * [[ | + | * [[Ephenidine]] |
| − | * [[ | + | * [[Fluorolintane]] |
| − | + | * [[Methoxphenidine]] | |
| − | + | ||
| − | + | |group9= [[Morphinan]]s | |
| − | + | |list9= | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | * [[ | ||
| − | |||
| − | |||
| − | | | ||
| − | | | ||
* [[Dextrallorphan]] | * [[Dextrallorphan]] | ||
* [[Dextromethorphan]] | * [[Dextromethorphan]] | ||
| Line 266: | Line 491: | ||
* [[Racemethorphan]] | * [[Racemethorphan]] | ||
* [[Racemorphan]] | * [[Racemorphan]] | ||
| − | | | + | |
| − | | | + | |group10= Others |
| + | |list10= | ||
| + | * [[2-EMSB]] | ||
* [[2-MDP]] | * [[2-MDP]] | ||
* [[8A-PDHQ]] | * [[8A-PDHQ]] | ||
* [[Aptiganel]] | * [[Aptiganel]] | ||
| + | * [[Budipine]] | ||
| + | * [[Delucemine]] | ||
* [[Dexoxadrol]] | * [[Dexoxadrol]] | ||
* [[Dizocilpine]] | * [[Dizocilpine]] | ||
* [[Etoxadrol]] | * [[Etoxadrol]] | ||
| + | * [[Herkinorin]] | ||
* [[Ibogaine]] | * [[Ibogaine]] | ||
* [[Midafotel]] | * [[Midafotel]] | ||
* [[NEFA (drug)|NEFA]] | * [[NEFA (drug)|NEFA]] | ||
| + | * [[Neramexane]] | ||
* [[Nitrous oxide]] | * [[Nitrous oxide]] | ||
* [[Noribogaine]] | * [[Noribogaine]] | ||
* [[Perzinfotel]] | * [[Perzinfotel]] | ||
| + | * [[RB-64]] | ||
* [[Remacemide]] | * [[Remacemide]] | ||
* [[Selfotel]] | * [[Selfotel]] | ||
* [[Xenon]] | * [[Xenon]] | ||
| + | |||
}} | }} | ||
| − | | | + | <!-- Number out of order to preserve odd/even colorations in template group display --> |
| − | | | + | | group4 = [[Deliriant]]s<br /><small>([[Muscarinic acetylcholine receptor|mAChR]]<br />[[Anticholinergic|antagonists]])</small> |
| − | + | | list4 = | |
* [[Atropine]] | * [[Atropine]] | ||
* [[Benactyzine]] | * [[Benactyzine]] | ||
| Line 295: | Line 528: | ||
* [[BRN-1484501]] | * [[BRN-1484501]] | ||
* [[Brompheniramine]] | * [[Brompheniramine]] | ||
| + | * [[3-Quinuclidinyl benzilate|BZ]] | ||
* [[CAR-226,086]] | * [[CAR-226,086]] | ||
* [[CAR-301,060]] | * [[CAR-301,060]] | ||
| Line 317: | Line 551: | ||
* [[EA-3580]] | * [[EA-3580]] | ||
* [[EA-3834]] | * [[EA-3834]] | ||
| + | * [[Elemicin]] | ||
* [[Flavoxate]] | * [[Flavoxate]] | ||
* [[Hyoscyamine]] | * [[Hyoscyamine]] | ||
| + | * [[N-Ethyl-3-piperidyl benzilate|JB-318]] | ||
| + | * [[N-Methyl-3-piperidyl benzilate|JB-336]] | ||
* [[Meclozine]] | * [[Meclozine]] | ||
* [[Mepyramine]] | * [[Mepyramine]] | ||
| − | * [[ | + | * [[Myristicin]] |
| − | |||
* [[Orphenadrine]] | * [[Orphenadrine]] | ||
* [[Oxybutynin]] | * [[Oxybutynin]] | ||
| Line 336: | Line 572: | ||
* [[WIN-2299]] | * [[WIN-2299]] | ||
| − | | | + | | group5 = Others |
| − | | | + | | list5 = |
| − | {{Navbox subgroup |evenodd=swap | + | {{Navbox|subgroup |evenodd=swap |
| − | | group1 = [[Cannabinoid]]s<br /> | + | | group1 = [[Cannabinoid]]s<br /><small>([[Cannabinoid receptor type 1|CB<sub>1</sub>]] agonists)</small> |
| list1 = | | list1 = | ||
| − | {{Navbox | + | {{Navbox|subgroup |
| − | | group1 = [[Phytocannabinoids]] | + | | group1 = [[Phytocannabinoids|Natural]] |
| list1 = | | list1 = | ||
| − | * [[ | + | * [[Salvinorin A]] |
* [[Tetrahydrocannabinol|THC (Dronabinol)]] | * [[Tetrahydrocannabinol|THC (Dronabinol)]] | ||
* [[THCV]] | * [[THCV]] | ||
| − | + | ||
| group2 = [[Synthetic cannabinoids|Synthetic]] | | group2 = [[Synthetic cannabinoids|Synthetic]] | ||
| list2 = | | list2 = | ||
| + | |||
| + | {{Navbox|subgroup | ||
| + | |||
| + | |group1=[[List of AM cannabinoids|AM-''x'']] | ||
| + | |list1= | ||
| + | * [[AM-087]] | ||
| + | * [[AM251|AM-251]] | ||
| + | * [[AM-279_(disambiguation)|AM-279]] | ||
| + | * [[AM-281_(disambiguation)|AM-281]] | ||
| + | * [[AM-356_(disambiguation)|AM-356]] | ||
| + | * [[AM-374_(disambiguation)|AM-374]] | ||
| + | * [[AM-381_(disambiguation)|AM-381]] | ||
| + | * [[AM-404]] | ||
| + | * [[AM-411]] | ||
| + | * [[AM-630]] | ||
| + | * [[AM-661]] | ||
| + | * [[AM-678]] | ||
| + | * [[AM-679 (cannabinoid)|AM-679]] | ||
| + | * [[AM-694]] | ||
| + | * [[AM-735]] | ||
| + | * [[AM-855]] | ||
| + | * [[AM-881]] | ||
| + | * [[AM-883]] | ||
| + | * [[AM-905]] | ||
| + | * [[AM-906]] | ||
| + | * [[AM-919]] | ||
| + | * [[AM-926]] | ||
| + | * [[AM-938]] | ||
| + | * [[AM-1116]] | ||
| + | * [[AM-1172]] | ||
| + | * [[AM-1220]] | ||
| + | * [[AM-1221]] | ||
| + | * [[AM-1235]] | ||
| + | * [[AM-1241]] | ||
| + | * [[AM-1248]] | ||
| + | * [[AM-1710]] | ||
| + | * [[AM-1714]] | ||
| + | * [[AM-1902]] | ||
| + | * [[AM-2201]] | ||
| + | * [[AM-2212]] | ||
| + | * [[AM-2213]] | ||
| + | * [[AM-2232]] | ||
| + | * [[AM-2233]] | ||
| + | * [[AM-2389]] | ||
| + | * [[AM-3102]] | ||
| + | * [[AM-4030]] | ||
| + | * [[AM-4054]] | ||
| + | * [[AM-4056]] | ||
| + | * [[AM-4113]] | ||
| + | * [[AM-6545]] | ||
| + | |||
| + | |group2=[[List of CP cannabinoids|CP ''x'']] | ||
| + | |list2= | ||
* [[CP 47,497]] | * [[CP 47,497]] | ||
* [[CP 55,244]] | * [[CP 55,244]] | ||
* [[CP 55,940]] | * [[CP 55,940]] | ||
| − | * [[ | + | * [[(±)-CP 55,940]] |
| + | * [[(+)-CP 55,940]] | ||
| + | * [[(-)-CP 55,940]] | ||
| + | |||
| + | |group3=[[List of HU cannabinoids|HU-''x'']] | ||
| + | |list3= | ||
* [[HU-210]] | * [[HU-210]] | ||
| + | * [[HU-211]] | ||
| + | * [[HU-239]] | ||
| + | * [[HU-243]] | ||
| + | * [[HU-308]] | ||
| + | * [[HU-320]] | ||
| + | * [[HU-331]] | ||
| + | * [[HU-336]] | ||
| + | * [[HU-345]] | ||
| + | |||
| + | |group4=[[List of JWH cannabinoids|JWH-''x'']] | ||
| + | |list4= | ||
| + | * [[JWH-007]] | ||
| + | * [[JWH-015]] | ||
* [[JWH-018]] | * [[JWH-018]] | ||
| + | * [[JWH-019]] | ||
* [[JWH-030]] | * [[JWH-030]] | ||
| + | * [[JWH-047]] | ||
| + | * [[JWH-048]] | ||
| + | * [[JWH-051]] | ||
| + | * [[JWH-057]] | ||
* [[JWH-073]] | * [[JWH-073]] | ||
* [[JWH-081]] | * [[JWH-081]] | ||
| + | * [[JWH-098]] | ||
| + | * [[JWH-116]] | ||
| + | * [[JWH-120]] | ||
| + | * [[JWH-122]] | ||
| + | * [[JWH-133]] | ||
| + | * [[JWH-139]] | ||
| + | * [[JWH-147]] | ||
| + | * [[JWH-148]] | ||
| + | * [[JWH-149]] | ||
| + | * [[JWH-149]] | ||
| + | * [[JWH-161]] | ||
| + | * [[JWH-164]] | ||
| + | * [[JWH-166]] | ||
| + | * [[JWH-167]] | ||
| + | * [[JWH-171]] | ||
| + | * [[JWH-175]] | ||
| + | * [[JWH-176]] | ||
| + | * [[JWH-181]] | ||
| + | * [[JWH-182]] | ||
| + | * [[JWH-184]] | ||
| + | * [[JWH-185]] | ||
| + | * [[JWH-192]] | ||
| + | * [[JWH-193]] | ||
| + | * [[JWH-194]] | ||
| + | * [[JWH-195]] | ||
| + | * [[JWH-196]] | ||
| + | * [[JWH-197]] | ||
| + | * [[JWH-198]] | ||
| + | * [[JWH-199]] | ||
* [[JWH-200]] | * [[JWH-200]] | ||
| + | * [[JWH-203]] | ||
| + | * [[JWH-205]] | ||
| + | * [[JWH-210]] | ||
| + | * [[JWH-210]] | ||
| + | * [[JWH-213]] | ||
| + | * [[JWH-220]] | ||
| + | * [[JWH-229]] | ||
| + | * [[JWH-234]] | ||
| + | * [[JWH-249]] | ||
* [[JWH-250]] | * [[JWH-250]] | ||
| + | * [[JWH-251]] | ||
| + | * [[JWH-253]] | ||
| + | * [[JWH-258]] | ||
| + | * [[JWH-300]] | ||
| + | * [[JWH-302]] | ||
| + | * [[JWH-307]] | ||
| + | * [[JWH-336]] | ||
| + | * [[JWH-350]] | ||
| + | * [[JWH-359]] | ||
| + | * [[JWH-387]] | ||
| + | * [[JWH-398]] | ||
| + | * [[JWH-424]] | ||
| + | |||
| + | |group5=[[List of miscellaneous designer cannabinoids|Misc. designer cannabinoids]] | ||
| + | |list5= | ||
| + | * [[4-HTMPIPO]] | ||
| + | * [[5F-AB-FUPPYCA]] | ||
| + | * [[5F-AB-PINACA]] | ||
| + | * [[5F-ADB]] | ||
| + | * [[5F-ADB-PINACA]] | ||
| + | * [[5F-ADBICA]] | ||
| + | * [[5F-AMB]] | ||
| + | * [[5F-APINACA]] | ||
| + | * [[5F-CUMYL-PINACA]] | ||
| + | * [[5F-NNE1]] | ||
| + | * [[5F-PB-22]] | ||
| + | * [[5F-SDB-006]] | ||
| + | * [[A-796,260]] | ||
| + | * [[A-836,339]] | ||
| + | * [[AB-001]] | ||
| + | * [[AB-005]] | ||
| + | * [[AB-CHFUPYCA]] | ||
| + | * [[AB-CHMINACA]] | ||
| + | * [[AB-FUBINACA]] | ||
| + | * [[AB-PINACA]] | ||
| + | * [[ADAMANTYL-THPINACA]] | ||
| + | * [[ADB-CHMINACA]] | ||
| + | * [[ADB-FUBINACA]] | ||
| + | * [[ADB-PINACA]] | ||
| + | * [[ADBICA]] | ||
| + | * [[ADSB-FUB-187]] | ||
| + | * [[AMB-FUBINACA]] | ||
| + | * [[APICA (synthetic cannabinoid drug)|APICA]] | ||
| + | * [[APINACA]] | ||
| + | * [[APP-FUBINACA]] | ||
| + | * [[CB-13]] | ||
| + | * [[CUMYL-PICA]] | ||
| + | * [[CUMYL-PINACA]] | ||
| + | * [[CUMYL-THPINACA]] | ||
| + | * [[Dimethylheptylpyran|DMHP]] | ||
| + | * [[EAM-2201]] | ||
| + | * [[FAB-144]] | ||
| + | * [[FDU-PB-22]] | ||
| + | * [[FUB-144]] | ||
| + | * [[FUB-APINACA]] | ||
| + | * [[FUB-JWH-018]] | ||
| + | * [[FUB-PB-22]] | ||
| + | * [[FUBIMINA]] | ||
| + | * [[JTE 7-31]] | ||
| + | * [[JTE-907]] | ||
* [[Levonantradol]] | * [[Levonantradol]] | ||
| + | * [[MDMB-CHMICA]] | ||
| + | * [[MDMB-CHMINACA]] | ||
| + | * [[MDMB-FUBINACA]] | ||
| + | * [[MEPIRAPIM]] | ||
| + | * [[MAM-2201]] | ||
| + | * [[MDA-19]] | ||
| + | * [[MN-18]] | ||
| + | * [[MN-25]] | ||
| + | * [[NESS-0327]] | ||
| + | * [[NESS-040C5]] | ||
* [[Nabilone]] | * [[Nabilone]] | ||
* [[Nabitan]] | * [[Nabitan]] | ||
| + | * [[NM-2201]] | ||
| + | * [[NNE1]] | ||
| + | * [[Org 28611]] | ||
* [[Parahexyl]] | * [[Parahexyl]] | ||
| + | * [[PTI-1]] | ||
| + | * [[PTI-2]] | ||
| + | * [[PX-1]] | ||
| + | * [[PX-2]] | ||
| + | * [[PX-3]] | ||
| + | * [[QUCHIC]] | ||
| + | * [[QUPIC]] | ||
| + | * [[RCS-4]] | ||
| + | * [[RCS-8]] | ||
| + | * [[SDB-005]] | ||
| + | * [[SDB-006]] | ||
| + | * [[STS-135_(drug)|STS-135]] | ||
* [[THC-O-acetate]] | * [[THC-O-acetate]] | ||
* [[THC-O-phosphate]] | * [[THC-O-phosphate]] | ||
| + | * [[THJ-018]] | ||
| + | * [[THJ-2201]] | ||
| + | * [[UR-144]] | ||
* [[WIN 55,212-2]] | * [[WIN 55,212-2]] | ||
| + | * [[XLR-11]] | ||
| + | }} | ||
| + | |||
| + | |||
}} | }} | ||
| − | | group2 = [[Dopamine receptor D2|D<sub>2</sub> | + | | group2 = [[Dopamine receptor D2|D<sub>2</sub>]] [[Dopamine agonist|agonists]] |
| list2 = | | list2 = | ||
| + | * [[Apomorphine]] | ||
* [[Aporphine]] | * [[Aporphine]] | ||
* [[Bromocriptine]] | * [[Bromocriptine]] | ||
* [[Cabergoline]] | * [[Cabergoline]] | ||
* [[Lisuride]] | * [[Lisuride]] | ||
| + | * [[Lysergic acid diethylamide|LSD]] | ||
* [[Memantine]] | * [[Memantine]] | ||
* [[Nuciferine]] | * [[Nuciferine]] | ||
* [[Pergolide]] | * [[Pergolide]] | ||
| + | * [[Phenethylamine]] | ||
* [[Piribedil]] | * [[Piribedil]] | ||
* [[Pramipexole]] | * [[Pramipexole]] | ||
* [[Ropinirole]] | * [[Ropinirole]] | ||
* [[Rotigotine]] | * [[Rotigotine]] | ||
| − | | group3 = [[GABAA receptor|GABA<sub>A</sub> | + | * [[Salvinorin A]]<br /><small>Also indirect D<sub>2</sub> agonists, such as [[dopamine reuptake inhibitor]]s ([[cocaine]], [[methylphenidate]]), [[releasing agent]]s ([[amphetamine]], [[methamphetamine]]), and [[Precursor (chemistry)|precursors]] ([[L-DOPA|levodopa]]).</small> |
| + | |||
| + | | group3 = [[GABAA receptor|GABA<sub>A</sub>]]<br />enhancers | ||
| list3 = | | list3 = | ||
| − | * [[ | + | * [[CI-966]] |
| + | * [[Eszopiclone]] | ||
* [[Ibotenic acid]] | * [[Ibotenic acid]] | ||
| − | * [[Muscimol]] | + | * [[Muscimol]] (''[[Amanita muscaria]]'') |
| − | | group4 = [[Inhalant]]s<br /> | + | * [[Zaleplon]] |
| + | * [[Zolpidem]] | ||
| + | * [[Zopiclone]] | ||
| + | |||
| + | | group4 = [[Inhalant]]s<br /><small>(Mixed [[Mechanism of action|MOA]])</small> | ||
| list4 = | | list4 = | ||
* [[Aliphatic hydrocarbons]] | * [[Aliphatic hydrocarbons]] | ||
| Line 402: | Line 854: | ||
** [[Chlorofluorocarbon]]s | ** [[Chlorofluorocarbon]]s | ||
** [[Chloroform]] | ** [[Chloroform]] | ||
| + | |||
| group5 = [[κ-opioid receptor|κOR]] [[Opioid|agonists]] | | group5 = [[κ-opioid receptor|κOR]] [[Opioid|agonists]] | ||
| list5 = | | list5 = | ||
* [[Salvinorin B ethoxymethyl ether|2-EMSB]] | * [[Salvinorin B ethoxymethyl ether|2-EMSB]] | ||
| − | |||
* [[Alazocine]] | * [[Alazocine]] | ||
* [[Bremazocine]] | * [[Bremazocine]] | ||
| + | * [[Butorphan]] | ||
* [[Butorphanol]] | * [[Butorphanol]] | ||
* [[Cyclazocine]] | * [[Cyclazocine]] | ||
| + | * [[Cyclorphan]] | ||
* [[Cyprenorphine]] | * [[Cyprenorphine]] | ||
| − | * [[ | + | * [[Diprenorphine]] |
| − | |||
* [[Enadoline]] | * [[Enadoline]] | ||
* [[Herkinorin]] | * [[Herkinorin]] | ||
| + | * [[Heroin]] | ||
* [[HZ-2]] | * [[HZ-2]] | ||
* [[Ibogaine]] | * [[Ibogaine]] | ||
* [[Ketazocine]] | * [[Ketazocine]] | ||
| + | * [[Levallorphan]] | ||
| + | * [[Levomethorphan]] | ||
| + | * [[Levorphanol]] | ||
* [[LPK-26]] | * [[LPK-26]] | ||
* [[Metazocine]] | * [[Metazocine]] | ||
| + | * [[Morphine]] | ||
* [[Nalbuphine]] | * [[Nalbuphine]] | ||
| + | * [[Nalmefene]] | ||
* [[Nalorphine]] | * [[Nalorphine]] | ||
* [[Noribogaine]] | * [[Noribogaine]] | ||
| + | * [[Oxilorphan]] | ||
* [[Pentazocine]] | * [[Pentazocine]] | ||
* [[Phenazocine]] | * [[Phenazocine]] | ||
| + | * [[Proxorphan]] | ||
| + | * [[Racemethorphan]] | ||
| + | * [[Racemorphan]] | ||
* [[Salvinorin A]] | * [[Salvinorin A]] | ||
* [[Spiradoline]] | * [[Spiradoline]] | ||
| Line 430: | Line 893: | ||
* [[U-50488]] | * [[U-50488]] | ||
* [[U-69,593]] | * [[U-69,593]] | ||
| − | | group6 = [[ | + | * [[Xorphanol]] |
| + | |||
| + | | group6 = [[Oneirogen|Oneirogens]] | ||
| list6 = | | list6 = | ||
| − | * [[ | + | * [[Calea ternifolia|Calea zacatechichi]] |
| − | * [[ | + | * [[Silene undulata|Silene capensis]] |
| − | * [[ | + | * [[Galantamine]] |
| − | + | ||
| − | | group7 = | + | | group7 = Others |
| list7 = | | list7 = | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
* [[Glaucine]] | * [[Glaucine]] | ||
* [[Isoaminile]] | * [[Isoaminile]] | ||
| + | * [[Noscapine]] | ||
* [[Pukateine]] | * [[Pukateine]] | ||
}} | }} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | [[Category: | + | [[Category:Psychoactive drug templates]] |
</noinclude> | </noinclude> | ||
Latest revision as of 01:11, 16 January 2021
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Hallucinogens|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Hallucinogens|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Hallucinogens|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.